NeurogesX is a biopharmaceutical company focused on developing and commercializing pain management therapies.
What is NeurogesX' ticker symbol and on what exchange does it trade?
NeurogesX' shares trade on the NASDAQ Global Market under the stock ticker symbol "NGSX."
Where and when was NeurogesX incorporated?
NeurogesX was incorporated in California on May 28, 1998. The Company was reincorporated into Delaware in February, 2007.
When was NeurogesX' initial public offering, and what was the offering price?
NeurogesX went public on May 2nd, 2007 and the offering price was $11.00.
Where is NeurogesX headquartered?
NeurogesX is headquartered at 2215 Bridgepointe Parkway, Suite 200, San Mateo, CA 94404
When does the NeurogesX fiscal year end?
NeurogesX operates on a December 31 fiscal year end.
Who is NeurogesX' independent auditor?
NeurogesX' independent auditor is Ernst & Young LLP.
Who is the Company's outside legal counsel?
The Company's outside legal counsel is Wilson Sonsini Goodrich & Rosati, P.C. They are located at 650 Page Mill Road, Palo Alto, CA 94304-1050. Their phone number is (650) 493-9300.
Who are the Company's officers and directors?
NeurogesX officers and directors can be found in the "About NeurogesX" of the Web site.
Who is NeurogesX' transfer agent, and how does one contact the transfer agent regarding stock certificates or change of address?
The Company's transfer agent is Wells Fargo Bank N.A. Its address is 161 North Concord Exchange South St. Paul, MN 55075-1139. The contact phone number is (800) 468-9716 or (651) 450-4064.
Does NeurogesX currently pay a dividend on its common stock?
NeurogesX does not currently pay a dividend on its common stock.
Does NeurogesX offer a direct stock purchase plan?
NeurogesX does not currently offer a direct stock purchase plan. Shares can be purchased through a broker of your choice.
What is NeurogesX' CUSIP number?
NeurogesX' CUSIP number is 641252101
How can I contact someone at NeurogesX with a question or request?
Please visit the Contact Us page on the Company Web site where an email addresses and contact form is provided. Additionally, NeurogesX can be reached by calling 650-358-3300.
How can I find information on NeurogesX' SEC filings?
NeurogesX' SEC filings can be obtained by visiting www.sec.gov or by visiting the SEC filing page under the Financial Information heading in the Investor Relations section of the Company's Web site.
Who handles investor relations for NeurogesX?
The Ruth Group is NeurogesX investor relations agency of record. For additional information, please contact:
show all
hide all